3D Bioprinting Market

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024

Report Code: BT 4971 Sep, 2019, by marketsandmarkets.com

[183 Pages Report] The 3D bioprinting market is projected to reach USD 1,647 Million by 2024 from USD 651 Million in 2019, at a CAGR of 20.4% from 2019 to 2024. Increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market; and rising adoption of 3D bioprinting in the pharmaceutical and cosmetology industries will fuel the market growth over the forecast period.

3D Bioprinting Market Dynamics

The 3D bioprinters segment accounted for the largest share of the 3D bioprinting market, by component, in 2018

Based on component, the market is segmented into 3D bioprinters and bioinks. The 3D bioprinters market is further segmented on the basis of technology into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, microextrusion bioprinting, and other technologies; whereas bioinks segment is further sub-segmented into natural, synthetic, and hybrid bioinks. The 3D bioprinters segment is anticipated to hold major market share owing to the new product launches and approvals. Moreover, rising R&D activities and funding support by government authorities are further supporting the growth of this segment.

The research application segment, to register significant growth over the forecast period

In terms of application, the market is segmented into research applications and clinical applications. The market for research applications is further sub segmented into drug research, regenerative medicine, and 3D cell culture; while, the clinical application segment is further divided into skin, bone & cartilage, blood vessels, and other clinical applications. Rising adoption of the 3D bioprinting technology by biopharmaceutical companies is the key factors attributed to the growth of research applications over the forecast period.

Living cells segment commanded the leading market share due to the rising preference for regenerative research

Based on material, the market is broadly segmented into hydrogels, extracellular matrices, living cells, and other biomaterials. Among these, the living cells segment accounted for the largest market share. Significant share of the segment are attributed to growing R&D in the fields of regenerative medicine and stem cell research globally.

The research organizations & academic institutes end-user segment garnered the highest revenue in the 3D bioprinting market in 2018 

Based on end-user, the market is segmented into hospitals, research organizations & academic institutes, and biopharmaceutical companies. The research organizations & educational institutes segment accounted for the largest share of the market in 2018. Various research organizations across the globe are using 3D bioprinting intending to advance medical treatment. In line with this, academic & research institutes are collaborating with key market players for developing novel 3D bioprinted products. For instance, in 2019, Aspect Biosystems (Canada) and the National Research Council of Canada collaborated to create a new 3D therapeutic model for the treatment of various central nervous system diseases, including Alzheimer’s disease

The Asia Pacific market is expected to grow at the highest CAGR during the forecast period

The 3D bioprinting market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and Rest of the World (Latin America, and the Middle East and Africa). The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, driven by the increasing research activities, growing demand for organ transplants, increasing number of initiatives by market players on expanding their presence in the APAC, and higher adoption of stem cell research. China and India are expected to offer significant growth opportunities for players in the market, owing to growing support from government bodies and an increasing number of conferences held in these countries.

3D Bioprinting Market Dynamics

Key Market Players

The major players in the market include Organovo Holdings Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China) among others.

An analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, partnerships, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the market. Among these business strategies, partnerships and agreements were the most widely adopted growth strategies by market players.

CELLINK (Sweden) has emerged as a key player in the market in 2018, owing to its vast product portfolio and strong focus on technological advancements and expanding its geographical reach. The company is currently focusing on the strategy of mergers & acquisitions to strengthen its product offerings further. For instance, in 2019, CELLINK (Sweden) acquired all of Cytena GmbH (Germany) shares to improve its product offerings. With this acquisition, cytena’s patented single-cell printer technology was added to CELLINK’s portfolio.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019–2024

Forecast Units

Value (USD)

Segments Covered

Component, Application, Material, End User, and Region

Geographies Covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies Covered

The major players in the market include Organovo Holdings Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China) among others.

This research report categorizes the market, by component, application, material, end-user, and region.

3D bioprinting Market, by Component

  • 3D Bioprinters
    • Magnetic 3d bioprinting
    • Laser-assisted bioprinting
    • Inkjet 3d bioprinting
    • Microextrusion bioprinter
    • Other Bioprinters
  • Bioinks
    • Natural bioinks
    • Synthetic bioinks
    • Hybrid bioinks

3D bioprinting Market, by Application

  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3d Cell Culture
  • Clinical Applications
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Others

3D bioprinting Market, by Material

  • Hydrogels
  • Extracellular Matrices
  • Living Cells
  • Other Biomaterials

3D bioprinting Market, by End User

  • Hospitals
  • Research Organizations and Academic Institutes
  • Biopharmaceutical Companies

3D bioprinting Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • RoAPAC
  • Rest of the World
    • Latin America
    • The Middle East and Africa

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of 3D bioprinting devices across the globe in the future?
  • Which component will register the highest adoption rate during the forecast period?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • Emerging countries have immense opportunities for the growth and adoption of 3D bioprinters and bioinks. Will this scenario continue in the next five years?
  • Which end-users are estimated to adopt 3D bioprinting technology?
  • What are the key strategies adopted by the key players operating in the market?
  • What are the upcoming market trends?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 36)
    4.1 3D Bioprinting Market Overview
    4.2 Market Share, By Component and Region
    4.3 Market, By Material, 2019 vs 2024 (USD Million)
    4.4 Market, By End User, 2019 vs 2024 (USD Million)
    4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 3D Bioprinting Approaches
           5.2.1 Biomimicry
           5.2.2 Autonomous Self-Assembly
           5.2.3 Mini-Tissue Building Blocks
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
                    5.3.1.2 Rising Public and Private Funding to Support Bioprinting Research Activities
                    5.3.1.3 Technological Advancements in the 3D Bioprinting Industry
           5.3.2 Restraints
                    5.3.2.1 Dearth of Skilled Professionals
                    5.3.2.2 High Development & Production Costs
                    5.3.2.3 Lack of Regulatory Guidelines Governing 3D Bioprinting
           5.3.3 Opportunities
                    5.3.3.1 Rising Demand for Organ Transplants
                    5.3.3.2 Growing Awareness of 3D Bioprinting
                    5.3.3.3 Growing Demand for Regenerative Medicine & Stem Cell Research
           5.3.4 Challenges
                    5.3.4.1 Socioethical Concerns Related to the Use of 3D Bioprinted Products
                    5.3.4.2 High Cost of 3D Bioprinting
                    5.3.4.3 Process Control & Understanding

6 3D Bioprinting Market, By Component (Page No. - 49)
    6.1 Introduction
    6.2 3D Bioprinters
           6.2.1 3D Bioprinters Market, By Technology
                    6.2.1.1 Microextrusion Bioprinting
                               6.2.1.1.1 Increasing Research in the Field of Microextrusion is Fueling the Adoption of This Technology
                    6.2.1.2 Inkjet 3D Bioprinting
                               6.2.1.2.1 High Cell Viability and Low Cost have Resulted in the Increased Demand for Inkjet 3D Bioprinting
                    6.2.1.3 Laser-Assisted Bioprinting
                               6.2.1.3.1 Laser-Assisted Bioprinting is One of the Highest-Resolution Bioprinting Technologies Available in the 3D Bioprinting Industry
                    6.2.1.4 Magnetic 3D Bioprinting
                               6.2.1.4.1 Accuracy and Speed in the Formation and Processing of Cultured Tissues are the Major Advantages Associated With Magnetic 3D Bioprinting
                    6.2.1.5 Other Technologies
    6.3 Bioinks
           6.3.1 Natural Bioinks
                    6.3.1.1 Natural Bioinks are the Most Commonly Preferred Bioinks in the 3D Bioprinting Process
           6.3.2 Hybrid Bioinks
                    6.3.2.1 Hybrid Bioinks Possess High Mechanical Strength and Great Biocompatibility
           6.3.3 Synthetic Bioinks
                    6.3.3.1 Improved Mechanical Strength and Consistency Offered By Synthetic Bioinks to Drive Market Growth

7 3D Bioprinting Market, By Material (Page No. - 61)
    7.1 Introduction
    7.2 Living Cells
           7.2.1 Ethical Issues Associated With the Use of Living Cells in Organ Development to Hamper Market Growth
    7.3 Hydrogels
           7.3.1 Dynamic Properties of Hydrogels are Supporting Their Increased Use in 3D Tissue Engineering and Biomedical Applications
    7.4 Extracellular Matrices
           7.4.1 Ecm has Emerged as A Promising Tool in Tissue Engineering
    7.5 Other Biomaterials

8 3D Bioprinting Market, By Application (Page No. - 67)
    8.1 Introduction
    8.2 Research Applications
           8.2.1 Drug Research
                    8.2.1.1 Drug Research Segment to Register the Highest Growth During the Forecast Period
           8.2.2 Regenerative Medicine
                    8.2.2.1 Growing Demand for Organ Transplants to Support Market Growth
           8.2.3 3D Cell Culture
                    8.2.3.1 Rising Focus on Developing Alternatives to Animal Testing to Support Market Growth
    8.3 Clinical Applications
           8.3.1 Skin
                    8.3.1.1 Growing Number of Aesthetic and Reconstruction Surgeries to Propel Market Growth
           8.3.2 Bone & Cartilage
                    8.3.2.1 Increasing Incidence of Musculoskeletal Conditions to Drive the Demand for Bone Grafts
           8.3.3 Blood Vessels
                    8.3.3.1 Increasing Research Activities Focused on the 3D Bioprinting of Blood Vessels is the Major Factor Driving Market Growth
           8.3.4 Other Clinical Applications

9 3D Bioprinting Market, By End User (Page No. - 78)
    9.1 Introduction
    9.2 Research Organizations & Academic Institutes
           9.2.1 Research Organizations & Academic Institutes are the Fastest-Growing End Users of 3D Bioprinting
    9.3 Biopharmaceutical Companies
           9.3.1 Increasing Prevalence of Chronic Diseases to Drive the Adoption of 3D Bioprinting Among Biopharmaceutical Companies
    9.4 Hospitals
           9.4.1 3D Printing Offers A Customized Surgical Planning Tool for Hospitals

10 3D Bioprinting Market, By Region (Page No. - 83)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 The US Dominates the Global Market
             10.2.2 Canada
                        10.2.2.1 Government Initiatives to Support the Growth of the Market in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Increasing Demand for Organ Transplants to Drive Market Growth
             10.3.2 UK
                        10.3.2.1 Increase in Funding and Grants to Support Research Activities Related to 3D Bioprinting in the UK
             10.3.3 France
                        10.3.3.1 Growing Cosmetics Industry in France to Propel the Adoption of 3D Bioprinting Technologies
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
                        10.4.1.1 Strong Research Base and Government Support to Drive the Growth of the Market in Japan
             10.4.2 China
                        10.4.2.1 The Market in China is Projected to Register Significant Growth Owing to Rising Regenerative Medicine Research
             10.4.3 India
                        10.4.3.1 Initiatives to Raise Awareness and Develop Novel Products to Support Market Growth in India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World
             10.5.1 Latin America
                        10.5.1.1 Growing Medical Tourism to Contribute to the Growth of the Market in the Region
             10.5.2 Middle East & Africa
                        10.5.2.1 Lack of Awareness and Underdeveloped Infrastructure to Hamper Market Growth

11 Competitive Landscape (Page No. - 142)
     11.1 Introduction
     11.2 Market Ranking Analysis
     11.3 Competitive Scenario
     11.4 Competitive Leadership Mapping
     11.5 Vendor Inclusion Criteria
     11.6 Vendor Dive
             11.6.1 Visionary Leaders
             11.6.2 Innovators
             11.6.3 Dynamic Differentiators
             11.6.4 Emerging Companies

12 Company Profiles (Page No. - 149)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Advanced Solutions Life Sciences
     12.2 Allevi Inc.
     12.3 Aspect Biosystems Ltd.
     12.4 Cellink
     12.5 Cyfuse Biomedical K.K.
     12.6 Digilab, Inc.
     12.7 Envisiontec
     12.8 Gesim
     12.9 Nano3D Biosciences, Inc.
     12.10 Organovo Holdings, Inc.
     12.11 Poietis
     12.12 Regenhu
     12.13 Regenovo Biotechnology Co., Ltd.
     12.14 Rokit Healthcare
     12.15 Tevido Biodevices

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 174)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (172 Tables)

Table 1 3D Bioprinting Market, By Component, 2017–2024 (USD Million)
Table 2 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 3 3D Bioprinters Market, By Region, 2017–2024 (USD Million)
Table 4 Microextrusion Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 5 Inkjet Market, By Region, 2017–2024 (USD Million)
Table 6 Laser-Assisted Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 7 Magnetic 3D Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 8 3D Bioprinters Market for Other Technologies, By Region, 2017–2024 (USD Million)
Table 9 Bioinks Market, By Type, 2017–2024 (USD Million)
Table 10 Bioinks Market, By Region, 2017–2024 (USD Million)
Table 11 Natural Bioinks Market, By Region, 2017–2024 (USD Million)
Table 12 Hybrid Bioinks Market, By Region, 2017–2024 (USD Million)
Table 13 Synthetic Bioinks Market, By Region, 2017–2024 (USD Million)
Table 14 Market, By Material, 2017–2024 (USD Million)
Table 15 Market for Living Cells, By Region, 2017–2024 (USD Million)
Table 16 Market for Hydrogels, By Region, 2017–2024 (USD Million)
Table 17 Market for Extracellular Matrices, By Region, 2017–2024 (USD Million)
Table 18 Market for Other Biomaterials, By Region, 2017–2024 (USD Million)
Table 19 Market, By Application, 2017–2024 (USD Million)
Table 20 Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 21 Market for Research Applications, By Region, 2017–2024 (USD Million)
Table 22 Market for Drug Research, By Region, 2017–2024 (USD Million)
Table 23 Market for Regenerative Medicine, By Region, 2017–2024 (USD Million)
Table 24 Market for 3D Cell Culture, By Region, 2017–2024 (USD Million)
Table 25 Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 26 Market for Clinical Applications, By Region, 2017–2024 (USD Million)
Table 27 Market for Skin Printing Applications, By Region, 2017–2024 (USD Million)
Table 28 3D Bioprinting Market for Bone & Cartilage Printing Applications, By Region, 2017–2024 (USD Million)
Table 29 Market for Blood Vessel Printing Applications, By Region, 2017–2024 (USD Million)
Table 30 List of Ongoing Clinical Trials
Table 31 Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 32 Market, By End User, 2017–2024 (USD Million)
Table 33 Market for Research Organizations & Academic Institutes, By Region, 2017–2024 (USD Million)
Table 34 Market for Biopharmaceutical Companies, By Region, 2017–2024 (USD Million)
Table 35 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 36 Market, By Region, 2017–2024 (USD Million)
Table 37 North America: 3D Bioprinting Market, By Country, 2017–2024 (USD Million)
Table 38 North America: Market, By Component, 2017–2024 (USD Million)
Table 39 North America: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 40 North America: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 41 North America: Market, By Application, 2017–2024 (USD Million)
Table 42 North America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 43 North America: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 44 North America: Market, By Material, 2017–2024 (USD Million)
Table 45 North America: Market, By End User, 2017–2024 (USD Million)
Table 46 US: Market, By Component, 2017–2024 (USD Million)
Table 47 US: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 48 US: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 49 US: Market, By Application, 2017–2024 (USD Million)
Table 50 US: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 51 US: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 52 US: Market, By Material, 2017–2024 (USD Million)
Table 53 US: Market, By Component, 2017–2024 (USD Million)
Table 55 Canada: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 56 Canada: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 57 Canada: Market, By Application, 2017–2024 (USD Million)
Table 58 Canada: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 59 Canada: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 60 Canada: Market, By Material, 2017–2024 (USD Million)
Table 61 Canada: Market, By End User, 2017–2024 (USD Million)
Table 62 Europe: Market, By Country, 2017–2024 (USD Million)
Table 63 Europe: Market, By Component, 2017–2024 (USD Million)
Table 64 Europe: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 65 Europe: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 66 Europe: Market, By Application, 2017–2024 (USD Million)
Table 67 Europe: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 68 Europe: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 69 Europe: Market, By Material, 2017–2024 (USD Million)
Table 70 Europe: Market, By End User, 2017–2024 (USD Million)
Table 71 Germany: Market, By Component, 2017–2024 (USD Million)
Table 72 Germany: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 73 Germany: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 74 Germany: Market, By Application, 2017–2024 (USD Million)
Table 75 Germany: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 76 Germany: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 77 Germany: Market, By Material, 2017–2024 (USD Million)
Table 78 Germany: Market, By End User, 2017–2024 (USD Million)
Table 79 UK: Market, By Component, 2017–2024 (USD Million)
Table 80 UK: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 81 UK: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 82 UK: Market, By Application, 2017–2024 (USD Million)
Table 83 UK: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 84 UK: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 85 UK: Market, By Material, 2017–2024 (USD Million)
Table 86 UK: Market, By End User, 2017–2024 (USD Million)
Table 87 France: Market, By Component, 2017–2024 (USD Million)
Table 88 France: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 89 France: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 90 France: Market, By Application, 2017–2024 (USD Million)
Table 91 France: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 92 France: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 93 France: Market, By Material, 2017–2024 (USD Million)
Table 94 France: Market, By End User, 2017–2024 (USD Million)
Table 95 RoE: Market, By Component, 2017–2024 (USD Million)
Table 96 RoE: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 97 RoE: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 98 RoE: Market, By Application, 2017–2024 (USD Million)
Table 99 RoE: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 100 RoE: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 101 RoE: Market, By Material, 2017–2024 (USD Million)
Table 102 RoE: Market, By End User, 2017–2024 (USD Million)
Table 103 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Component, 2017–2024 (USD Million)
Table 105 Asia Pacific: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 106 Asia Pacific: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 107 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 108 Asia Pacific: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 109 Asia Pacific: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 110 Asia Pacific: Market, By Material, 2017–2024 (USD Million)
Table 111 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 112 Japan: Market, By Component, 2017–2024 (USD Million)
Table 113 Japan: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 114 Japan: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 115 Japan: Market, By Application, 2017–2024 (USD Million)
Table 116 Japan: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 117 Japan: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 118 Japan: Market, By Material, 2017–2024 (USD Million)
Table 119 Japan: Market, By End User, 2017–2024 (USD Million)
Table 120 China: Market, By Component, 2017–2024 (USD Million)
Table 121 China: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 122 China: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 123 China: 3D Bioprinting Market, By Application, 2017–2024 (USD Million)
Table 124 China: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 125 China: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 126 China: Market, By Material, 2017–2024 (USD Million)
Table 127 China: Market, By End User, 2017–2024 (USD Million)
Table 128 India: Market, By Component, 2017–2024 (USD Million)
Table 129 India: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 130 India: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 131 India: Market, By Application, 2017–2024 (USD Million)
Table 132 India: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 133 India: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 134 India: Market, By Material, 2017–2024 (USD Million)
Table 135 India: Market, By End User, 2017–2024 (USD Million)
Table 136 RoAPAC: Market, By Component, 2017–2024 (USD Million)
Table 137 RoAPAC: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 138 RoAPAC: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 139 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 140 RoAPAC: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 141 RoAPAC: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 142 RoAPAC: Market, By Material, 2017–2024 (USD Million)
Table 143 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 144 Rest of the World: Market, By Region, 2017–2024 (USD Million)
Table 145 Rest of the World: 3D Bioprinting Market, By Component, 2017–2024 (USD Million)
Table 146 Rest of the World: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 147 Rest of the World: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 148 Rest of the World: Market, By Application, 2017–2024 (USD Million)
Table 149 Rest of the World: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 150 Rest of the World: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 151 Rest of the World: Market, By Material, 2017–2024 (USD Million)
Table 152 Rest of the World: Market, By End User, 2017–2024 (USD Million)
Table 153 Latin America: Market, By Component, 2017–2024 (USD Million)
Table 154 Latin America: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 155 Latin America: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 156 Latin America: Market, By Application, 2017–2024 (USD Million)
Table 157 Latin America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 158 Latin America: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 159 Latin America: Market, By Material, 2017–2024 (USD Million)
Table 160 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 161 Middle East & Africa: Market, By Component, 2017–2024 (USD Million)
Table 162 Middle East & Africa: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 163 Middle East & Africa: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 164 Middle East & Africa: Market, By Application, 2017–2024 (USD Million)
Table 165 Middle East & Africa: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 166 Middle East & Africa: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 167 Middle East & Africa: Market, By Material, 2017–2024 (USD Million)
Table 168 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)
Table 169 Product Launches & Approvals
Table 170 Collaborations
Table 171 Expansions
Table 172 Acquisitions


List of Figures (25 Figures)

Figure 1 3D Bioprinting Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Overall 3D Bioprinting Market
Figure 6 Data Triangulation Methodology
Figure 7 Market Share, By Component, 2019 vs 2024
Figure 8 Market, By Application, 2019 vs 2024 (USD Million)
Figure 9 Market Share, By Material, 2019 vs 2024
Figure 10 Market, By End User, 2019 vs 2024 (USD Million)
Figure 11 Geographical Snapshot of the Market
Figure 12 Technological Advancements in 3D Bioprinters and Biomaterials to Drive Market Growth
Figure 13 North America is the Largest Regional Market for 3D Bioprinters and Bioinks
Figure 14 Living Cells Segment to Hold the Major Share of the Market During the Forecast Period
Figure 15 Research Organizations & Academic Institutes Will Register the Highest CAGR During the Forecast Period
Figure 16 China to Register the Highest CAGR During the Forecast Period
Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 Global Market Ranking, By Key Player, 2018
Figure 22 Competitive Leadership Mapping (Overall Market), 2018
Figure 23 Competitive Leadership Mapping (SME/Start-UPS), 2018
Figure 24 Cellink: Company Snapshot
Figure 25 Organovo Holdings, Inc.: Company Snapshot

The study involved four major activities in estimating the current size of the 3D bioprinting market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the market.

In-depth interviews were conducted with various primary respondents that mainly include key industry participants, medical practitioners, subject-matter experts (SMEs), C-level and D-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess prospects of the market.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the 3D bioprinting market scenario through secondary research. A significant number of primary interviews were conducted with both the demand (healthcare providers, research institutes, physicians, and healthcare professionals) and supply sides (developers, manufacturers, and distributors of 3D bioprinting products). The primaries interviewed for this study include experts from the 3D bioprinting industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering 3D bioprinting products across the globe), purchase managers in healthcare provider organizations, administrative heads of biopharmaceutical companies, stem cell banks, CROs, heads of research and academic institutes, and scientists.

Around 60% and 40% primary interviews were conducted with the supply and demand sides, respectively. A robust primary research methodology has been adopted to validate the contents of the report and to fill gaps. Telephonic and e-mail communications were adopted to conduct interviews (questionnaires were designed and sent to primary participants as per their convenience). The following is the breakdown of primary respondents:

3D Bioprinting Market Dynamics

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the size of the 3D bioprinting market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the market. All percentage shares split, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report. The research methodology used to estimate the market size includes the following:

  • Product mapping of various manufacturers for each component type of 3D bioprinting at the regional and country-level 
  • Relative adoption pattern of each 3D bioprinting technology among key end-users at the regional and country-level
  • Detailed primary research to gather quantitative information related to segments and subsegments at the region and country-level
  • Detailed secondary research to gauge prevailing market trends at the region and country-level

Data Triangulation

After arriving at the overall market size of the 3D bioprinting industry from the market estimation approach explained above, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact market value data, data triangulation, and market breakdown methodology methods were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand- and supply-side analysis.

Report Objectives

  • To define, describe, and forecast the 3D bioprinting market based on component, application, material, end-user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micro-markets concerning individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the revenue of the market segments for four main regions, namely, North America, Europe, Asia Pacific, and Rest of the World.
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers & acquisitions; business expansions and research & development activities in the market          

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present 3D bioprinting market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Report Code
BT 4971
Published ON
Sep, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Bioprinting Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home